Alvimopan: An oral, peripherally acting, μ-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction—A 21-day treatment-randomized clinical trial
Titel:
Alvimopan: An oral, peripherally acting, μ-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction—A 21-day treatment-randomized clinical trial
Auteur:
Paulson, Daniel M. Kennedy, Daniel T. Donovick, Roger A. Carpenter, Randall L. Cherubini, Maryann Techner, Lee Du, Wei Ma, Yuju Schmidt, William K. Wallin, Bruce Jackson, David